SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is gaining significant traction as investors rally around its narrative as the "third frog" in Matt Furie's iconic frog universe, positioned as a spiritual successor to Pepe. The community is actively building and discussing the project's long-term potential as a cornerstone "frog meta" asset, with supporters emphasizing its organic growth and cultural connection to the original Pepe creator.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is gaining traction as community members highlight its role as essential infrastructure for autonomous AI agents within the Base ecosystem. Investors are actively discussing the token's long-term utility, ongoing developer-led upgrades, and the potential for a supply shock as these agents increasingly require BNKR to fund compute operations.

KAIO provides institutional-grade real-world asset (RWA) tokenization infrastructure that seamlessly connects traditional investment funds with digital capital markets. Through its purpose-built protocol, KAIO enables leading global asset managers to issue and distribute regulated tokenized funds across multiple high-performance blockchain networks — including Ethereum, Sei, Hedera, Solana, Aptos, and others — significantly expanding global access to institutional-quality real-world asset strategies for qualified investors.   By tokenizing feeder structures and shares in flagship funds, KAIO brings onchain access to proven strategies such as the BlackRock ICS US Dollar Liquidity Fund (one of the world’s largest institutional money market funds), the Brevan Howard Master Fund, Hamilton Lane’s Senior Credit Opportunities Fund (SCOPE) via the HL SCOPE Access Fund, and Laser Digital’s Laser Carry Fund (LCF), among others. These tokenized vehicles deliver secure, compliant exposure to money market, macro, private credit, and alternative strategies while unlocking new levels of programmability, composability, and 24/7 liquidity in DeFi environments.

KAIO

KAIO is trending as market participants debate its potential as a real-world asset (RWA) play and watch for a technical reversal following recent volatility. While some investors are accumulating the asset in anticipation of a price breakout, others remain skeptical, fueling intense community discussion about the project's long-term utility versus its speculative nature.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is currently trending as investors debate the potential for a long-term turnaround, fueled by a strategic push into insurance-covered mental health services and the potential for AI-driven clinical intelligence. The community is sharply divided between those who believe the stock is deeply undervalued and positioned for a major recovery via institutional support and potential buybacks, and those frustrated by persistent lack of profitability and stagnant price action.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is seeing a massive surge in investor interest following news of a significant federal investment to launch a quantum chip foundry, which has solidified its position as a central player in the government's strategic quantum computing initiatives. The community is buzzing with comparisons to past large-cap tech rotations, with many active traders and long-term holders debating the stock's potential to reach new all-time highs as it shifts from a legacy model into a core infrastructure play.

Optical Cable Corp. engages in the business of manufacturing fiber optic and copper data communication cabling and connectivity solutions primarily for the enterprise market and various harsh environment, specialty markets, and the wireless carrier market offering integrated suites of high-quality products which operate as a system solution or seamlessly integrate with other components. Its products include fiber optic and copper cabling, hybrid cabling, fiber optic and copper connectors, specialty fiber optic, copper and hybrid connectors, fiber optic and copper patch cords, pre-terminated fiber optic and copper cable assemblies, racks, cabinets, datacom enclosures, patch panels, face plates, multimedia boxes, fiber optic reels, and other cable and connectivity management accessories. The company was founded on June 10, 1983 and is headquartered in Roanoke, VA.

Optical Cable Corp.

Optical Cable Corp. is capturing investor interest as a potential play on infrastructure and data center expansion, with the community actively debating whether its low-float status will trigger a significant breakout. While some participants are closely tracking potential hyperscaler contracts and fiber demand, others remain cautious about the stock's tendency to spike and subsequently fade.

PDD Holdings, Inc. is a multinational commerce group that owns and operates a portfolio of businesses. The company aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from increased productivity and new opportunities. It has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses. PDD Holdings was founded by Hua Lin Cai and Zheng Huang in 2015 and is headquartered in Dublin, Ireland.

PDD Holdings Inc - ADR

Pinduoduo Inc.

PDD is seeing heightened volatility as investors weigh strong earnings against management's cautious outlook on future growth and intensifying competition. The community remains divided, with some highlighting the stock's undervaluation and massive cash position, while others are wary of the potential for sustained downward pressure on the share price.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending due to a significant institutional partnership with the DTCC, which plans to use the Stellar network to tokenize and settle traditional financial assets. While some in the community are celebrating this as a major milestone for real-world asset utility and a catalyst for long-term growth, others remain skeptical, debating whether this is a genuine breakout or just another volatile cycle of retail speculation.

USDX is the crypto-backed native stablecoin of the Kava DeFi hub.

USDX Stablecoin

USDX is heavily featured in technical analysis discussions centered on Elliott Wave patterns and High-Frequency trade setups, with participants closely monitoring key support and resistance zones to gauge future direction. Traders are debating potential breakout scenarios and the stablecoin's broader role in evolving financial systems, while also weighing sentiment against recent market movements and macroeconomic indicators.

Global X Funds - Global X DAX Germany ETF

Global X DAX Germany ETF

The Global X DAX Germany ETF (DAX) is currently the focal point of community discussion as traders leverage Elliott Wave analysis to navigate its bullish recovery from recent lows. The conversation is driven by technical setups that suggest the index is carving out a structured path toward further upside, with market participants closely monitoring key support levels to identify high-probability entry points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TGTX well schucks, with the enhance data coming out earlier this week, I would have guessed a better week.

Tracer

Maximus

Gg allen

Dave Lahr

nurul

smelter

Ernest Benigno

Jule Kreyling

Mikey P

Ve St

StockTwits Web

TG Therapeutics Inc

 well schucks, with the enhance data coming out earlier this week, I would have guessed a better week.

Hodor

@Biocreeper i guess we&#39;re down about 15% from recent high? at least it&#39;s not 20-25%. although they&#39;ll probably continue to try to keep flushing it down the toilet.

 i guess we're down about 15% from recent high? at least it's not 20-25%. although they'll probably continue to try to keep flushing it down the toilet.

@Biocreeper If you truly believe in the story this is a great opportunity to buy more. I already added another 500 right at the bell. I dont think either new events we get this month will help share price. I feel the AZER Cel and the SUBQ phase 3 data is what rerates this stock. Everything else is really priced in.

 If you truly believe in the story this is a great opportunity to buy more. I already added another 500 right at the bell. I dont think either new events we get this month will help share price. I feel the AZER Cel and the SUBQ phase 3 data is what rerates this stock. Everything else is really priced in.

Jraven

@Biocreeper I agree but it’s always quite unpredictable with this stock. Always seems someone wants to hold it back and I am sure MW knows what’s going on. However I’m very pleased to see the solid enhance readout. That’s a big win for patient and infusion centre convenience. It really does cement briumvi as the only sensible option if patients want an infused treatment. Perhaps some neuros will start taking advantage of this asap and don’t wait for approval. Only downside is that each new patient is now worth a little less as losing the cost of the 150mg dose.

StockTwits for iOS

 I agree but it’s always quite unpredictable with this stock. Always seems someone wants to hold it back and I am sure MW knows what’s going on. However I’m very pleased to see the solid enhance readout. That’s a big win for patient and infusion centre convenience. It really does cement briumvi as the only sensible option if patients want an infused treatment. Perhaps some neuros will start taking advantage of this asap and don’t wait for approval. Only downside is that each new patient is now worth a little less as losing the cost of the 150mg dose.